Navigation Links
Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
Date:11/17/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  Prima Biomed Ltd. ... that is striving to become a leader in the ... recently announced that the final CVac data from the ... a clear trend for a clinically meaningful improvement in ... second remission patients. In the group of ...
(Date:5/21/2015)... May 21, 2015 W. R. ... manufacturing facility in Worms, Germany has received good ... subsidiary of the International Pharmaceutical Excipient Council (IPEC) ... that produce its SYLOID® FP brand of pharmaceutical ... certification, following the Curtis Bay, Maryland (USA) and ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
(Date:5/20/2015)... May 20, 2015 Veracyte, Inc ... data demonstrating the ability of the company,s molecular ... from other interstitial lung diseases (ILDs) using samples ... potential to help thousands of patients avoid invasive, ... IPF diagnosis – a frequent challenge for physicians ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Global Survey on Flow Cytometry Adoption Trends 2015 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5
... cell controlled by a synthetic genome. They now hope to use ... engineer bacteria specially designed to solve environmental or energy problems. ... , at the Science Express website, on Thursday, 20 ... society. The research team, led by Craig Venter of the ...
... , May 20 Dendreon Corporation (Nasdaq: DNDN ) today ... PROVENGE® (sipuleucel-T) clinical trials of an autologous cellular immunotherapy in advanced prostate cancer, ... Oncology (ASCO) in Chicago on Monday, June 7 at ... , , ...
... May 20 Today, world-renowned scientist Dr. ... at the J. Craig Venter Institute (JCVI) became the first ... news holds groundbreaking potential for solutions to a host of ... cleaning up pollution; creating new energy sources; producing clean water; ...
Cached Biology Technology:Scientists 'boot up' a bacterial cell with a synthetic genome 2Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting 2Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting 3Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting 4Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting 5Science Channel Announces the Debut of Exclusive Look Into Dr. J. Craig Venter's Creation of Synthetic Life 2Science Channel Announces the Debut of Exclusive Look Into Dr. J. Craig Venter's Creation of Synthetic Life 3
(Date:4/27/2015)... OXFORD, Conn. , Apr. 27, 2015 ... "Company"), a biometric authentication company focused on the growing ... will commence shipping to pre-order customers the first week ... pre-orders through the month of May. ... is a significant milestone for the company as Wocket® ...
(Date:4/17/2015)... Canada , April 17, 2015 ... growing security concerns, and technological advancement to drive ... until 2020   According ... Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems ... is projected to register growth at CAGR of ...
(Date:4/10/2015)... , April 10, 2015 ... addition of the "Security Competitive Profiles - NEC" ... http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to supply ... to the market, with a company focus on the ... anticipated. Winning opportunities in the ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2
... the latest issue of the journal Emerging Infectious ... the hyperboreal tundra, in connection with the tundra ... These findings indicate that resistance to antibiotics ... prospect for future health care. The scientists ...
... N.Y., JAN. 9, 2008 Not enough American women ... day can help prevent serious birth defects, and only ... essential nutrient beginning before pregnancy, two recent surveys show. ... beginning before pregnancy is crucial because birth defects of ...
... PA (January 11, 2008): Nucleonics, Inc., a ... of novel RNA interference (RNAi)-based therapeutics, announced today ... a Phase 1 human safety study of its ... infection, NUC B1000. NUC B1000 ( ...
Cached Biology News:High degree of resistance to antibiotics in Arctic birds 2New folic acid seal helps women choose enriched grain foods to help prevent birth defects 2New folic acid seal helps women choose enriched grain foods to help prevent birth defects 3Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic 2Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic 3